MedPath

Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

Completed
Conditions
Dry Eye Syndrome
Registration Number
NCT00893243
Lead Sponsor
Hospital de Sao Sebastiao
Brief Summary

Primary Purpose:

* To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®

Secondary Purpose:

* Subjective evaluation of symptomatology

* Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Informed Consent signed
  • Age >18 years and < 55 years
  • Daily wearer of soft contact lens and/or daily (> 4 hours/day) computer user
Exclusion Criteria
  • Dry eye Syndrome other than of evaporative etiology, according to DEWS
  • Ocular or systemic disease that can affect the normal tear film
  • Pregnancy or pregnancy risk (no contraceptive method), lactation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Serviço de Oftalmologia, Hospital de São Sebastião

🇵🇹

Santa maria da Feira, Portugal

Serviço de Oftalmologia, Hospital de São Sebastião
🇵🇹Santa maria da Feira, Portugal

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.